Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

INTRODUCTION: This study helps to define the implications of breast cancer anti-estrogen resistance 3 (BCAR3) in breast cancer and extends the current understanding of its molecular mechanism of action. BCAR3 has been shown to promote cell proliferation, migration and attachment to extracellular mat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Guo, Jimin, Canaff, Lucie, Rajadurai, Charles Vincent, Fils-Aimé, Nadège, Tian, Jun, Dai, Meiou, Korah, Juliana, Villatoro, Manuel, Park, Morag, Ali, Suhad, Lebrun, Jean-Jacques
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311507/
https://ncbi.nlm.nih.gov/pubmed/25499443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0476-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados